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Background: The assessment of hemodynamic status is a crucial task in the initial evaluation of trauma patients.
However, blood pressure and heart rate are often misleading, as multiple variables may impact these conventional
parameters. More reliable methods such as pulmonary artery thermodilution for cardiac output measuring would
be necessary, but its applicability in the Emergency Department is questionable due to their invasive nature.
Non-invasive cardiac output monitoring devices may be a feasible alternative.
Methods: A systematic literature review was conducted. Only studies that explicitly investigated non-invasive
hemodynamic monitoring devices in trauma patients were considered.
Results: A total of 7 studies were identified as suitable and were included into this review. These studies evaluated
in a total of 1,197 trauma patients the accuracy of non-invasive hemodynamic monitoring devices by comparing
measurements to pulmonary artery thermodilution, which is the gold standard for cardiac output measuring. The
correlation coefficients r between the two methods ranged from 0.79 to 0.92. Bias and precision analysis ranged
from -0.02 +/- 0.78 l/min/m2 to -0.14 +/- 0.73 l/min/m2. Additionally, data on practicality, limitations and clinical
impact of the devices were collected.
Conclusion: The accuracy of non-invasive cardiac output monitoring devices in trauma patients is broadly satisfactory.
As the devices can be applied very early in the shock room or even preclinically, hemodynamic shock may be recognized
much earlier and therapeutic interventions could be applied more rapidly and more adequately. The devices can be
used in the daily routine of a busy ED, as they are non-invasive and easy to master.
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When managing trauma patients, it is crucial to evaluate
the hemodynamic status to exclude hemorrhage. During
the initial assessment, blood pressure and heart rate are
commonly used to estimate blood loss. However, these
parameters may be altered due to pain, hypothermia,
neurogenic or cardiogenic shock or other factors related
to the patient or to the injury. Moreover, analgesic,
sedative or relaxing drugs may interfere with these
conventional vital signs, thus making their interpret-
ation difficult.* Correspondence: beat.schnuriger@gmail.com
1Department of Visceral and Transplant Surgery, Bern University Hospital,
Bern, Switzerland
3Department of Visceral Surgery and Medicine, Bern University Hospital, Bern,
Switzerland
Full list of author information is available at the end of the article
© 2015 Kuster et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Therefore, other diagnostic tools are required for
hemorrhage detection. It has been shown that cardiac
output is substantially different in hypotensive patients
with or without blood loss. Low cardiac output then
indicates blood loss, whereas normal or elevated car-
diac output implies that blood loss is unlikely and that
there may be other reasons for hypotension [1]. This is
in accordance with many studies that have demon-
strated that surviving patients exhibit significantly dif-
ferent hemodynamic patterns from non-survivors, and
that these differences are already apparent in the
Emergency Department (ED). For example, it has been
repeatedly shown that cardiac index is higher in survi-
vors than in non-survivors [2-8].
Pulmonary artery catheter thermodilution is considered
to be the gold standard for cardiac output measurement
[9]. Unfortunately, the invasive nature of this methodThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Study selection process.
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the ED [9,10]. Thus, thermodilution often cannot be used
early in the evaluation of trauma patients.
A non-invasive device that permits advanced
hemodynamic monitoring as soon as the patient ar-
rives in the ED or even preclinically would be of great
benefit in the assessment of the hemodynamic state.
However, before such a new device is introduced into
clinical routine, it needs to be assessed in controlled
clinical trials.
The purpose of this review is to evaluate the accuracy
and clinical applicability of non-invasive hemodynamic
monitoring devices in the early assessment of trauma
patients.
Methods
Search strategy
A systematic literature search was conducted using
PubMed as its primary source. Studies from January 1966
to July 2014 were considered. Multiple searches were
performed using the following keywords: non-invasive
hemodynamic monitoring AND/OR non-invasive car-
diac output monitoring AND/OR thoracic electrical
bioimpedance AND/OR impedance cardiography AND/
OR bioreactance AND/OR NICOM AND trauma. In
PubMed, the ‘related articles’ algorithm was employed to
identify additional articles. Moreover, bibliographies of ori-
ginal reports and reviews were screened for additional cita-
tions. Preliminary screening was performed utilizing titles
and abstracts. The full-length articles of potentially appro-
priate studies were retrieved for further screening.
Inclusion and exclusion criteria
Only those studies were considered for inclusion that
explicitly investigated the accuracy of non-invasive
hemodynamic monitoring devices in trauma patients
by comparing it to the pulmonary artery catheter ther-
modilution method (Figure 1). Devices were examined
that measure at least cardiac output through thoracic
electrical bioimpedance, or through variations of this
technology, such as bioreactance. Both prospective and
retrospective studies were considered for inclusion.
Studies in languages other than English, reviews, case
reports or case series of <10 patients, were not consid-
ered for inclusion.
Data extraction
Data was extracted on the accuracy of non-invasive
hemodynamic monitoring devices. The devices measure-
ments had to be compared to pulmonary artery catheter
thermodilution, the gold standard for cardiac output
measuring [9]. Correlation coefficients were taken from
the articles, together with bias and precision analysis be-
tween the non-invasive hemodynamic monitoring deviceand pulmonary artery catheter thermodilution. If obtain-
able, the limits of agreement were also extracted.
Besides data on accuracy, attention was paid to the
device’s usability in the ED, including advantages and
limitations due to the device’s mode of operations and
its mode of displaying data. Finally, the new devices’
possible clinical impact in the ED was considered.
Characteristics of devices
For non-invasive hemodynamic monitoring, the most
commonly used method is the thoracic electrical bioimpe-
dance technology. Eleven non-invasive disposable prewired
hydrogen electrodes need to be placed on predefined loca-
tions on the skin. Three electrodes function as electrocar-
diography leads and are placed across the precordium and
left shoulder [2,4-8,11-13]. The other eight are positioned
in pairs so that they lie over the top and bottom of the
lung [5,11]. Each pair consists of an injecting and a sens-
ing electrode. Two injecting electrodes are placed on the
lateral side of the neck, opposing each other, and the other
two on each side of the chest at the level of the xiphister-
nal joint. The injecting electrodes send a 100-kHz, 4-mA
alternating current through the patient’s thorax, and the
sensing electrodes measure voltage differences which
change during the cardiac cycle. Each contraction of the
hearth ejects the stroke volume into the aorta, which re-
duces the impedance (resistance) across the chest, as the
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ther than passing through the aerated alveoli of the lung.
Thus, an electrical pulsatile impedance curve is captured
by the sensing electrodes. This curve is used to calculate
the baseline impedance (Zo) and the first derivative of the
impedance waveform (dZ/dt). The bioimpedance signals
and the electrocardiogram are filtered with an all-integer-
coefficient filtering technology to decrease processing time.
The digital signal processing also uses time-frequency dis-
tributions to increase signal-to-noise ratios. Thus, the de-
vice is able to calculate stroke volume, which is multiplied
by heart rate to get cardiac output [11].
The bioreactance method is a modification of the thor-
acic electrical bioimpedance technology [10]. It is based
on an analysis of relative phase shifts of an oscillating
current that occur when this current traverses the thor-
acic cavity. Four dual-electrode stickers need to be
placed on the skin. Each sticker consists of an outer
injecting electrode that emits a high-frequency sine wave
into the body, and an inner receiver electrode that is
used by the voltage input amplifier. Two stickers are
placed left and right on the upper thorax, while the
other two are placed on the lower thorax. The stickers
on a given side of the body are paired, so that the cur-
rents are passed between the outer electrodes of the pair
and voltages are recorded from the inner electrodes. The
system detects the phase shift of the input signal relative
to the injected signal. The change in the phase shift over
time is correlated with the blood volume in the aorta,
which fluctuates with the cardiac cycle. This allows the
calculation of stroke volume [14].
Results
Study selection
Figure 1 shows the study selection process. A total of
114 studies were identified using the aforementionedTable 1 Evaluation studies on the accuracy of thoracic electri
Author, year Study design Device
Bishop et al.
1996 [15]
Prospective Renaissance Technologies
Shoemaker et al.
1998 [11]
Retrospective Renaissance Technologies
Velmahos et al.
1999 [2]
Prospective Renaissance Technologies
Velmahos et al.
1999 [3]
Prospective Renaissance Technologies
Shoemaker et al.
2001 [6]
Prospective IQ System; Wantagh Inc.
Brown et al.
2005 [13]
Retrospective IQ System; Wantagh Inc.
Shoemaker et al.
2006 [5]
Prospective IQ Model 101; Noninvasive Medical
Technologies LLC or PhysioFlow; VasoCOsearch strategy. The abstracts were screened, which
revealed 18 studies with the potential for inclusion.
After obtaining the full-length articles, a total of 7
studies were included [2,3,5,6,11,13,15]. Their publi-
cation dates ranged from 1996 to 2006. All these
studies compared the performance of a non-invasive
hemodynamic monitoring device to the invasive pul-
monary artery thermodilution method. They are sum-
marized in Table 1.
The seven studies used devices that are based on thoracic
electrical bioimpedance methodology [2,3,5,6,11,13,15].
These devices included a system from Renaissance
Technologies, Newtown, Pennsylvania, the IQ System
from Wantagh Inc., Bristol, Pennsylvania, the IQ Model
101 from Noninvasive Medical Technologies LLC, Las
Vegas, Nevada, and the PhysioFlow from VasoCOM,
Bristol, Pennsylvania.
Accuracy of devices
Seven studies evaluated the accuracy of the cardiac out-
put measurements by a thoracic electrical bioimpedance
device and correlated this with the measurements of the
invasive pulmonary artery catheter thermodilution
method [2,3,5,6,11,13,15]. Table 1 gives an overview of
the studies designs, the devices used and the data that
was extracted.
All authors calculated the correlation coefficient, by
comparing the cardiac output measured by the thoracic
electrical bioimpedance device to the invasive thermodi-
lution method. Moreover, all but one study conducted a
bias and precision analysis [3,5,6,11,13,15]. The newest
study also calculated the limits of agreement between
the two methods [5].
Four studies published between 1996 and 1999 used a
“new thoracic electrical bioimpedance device”, developed
by Renaissance Technology, Newtown, Pennsylvaniacal bioimpedance devices
Patients Correlation
coefficient r
r2 Bias and precision
(l/min/m2)
54 patients with
gunshot wounds
0.79 0.62 −0.011
268 (139 trauma
patients)
0.83 0.68 −0.058 +/- 0.78
38 severely
traumatized patients
0.91 0.83 -
134 blunt trauma
patients
0.83 0.69 −0.02 +/- 0.78
151 trauma patients 0.91 0.83 −0.3 +/- 1.1
285 critically injured
patients
0.84 0.71 −0.14 +/-0.73
M
267 trauma patients 0.92 0.84 −0.07 +/- 0.47
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et al. in 1996 [15]. Here, patients with gunshot wounds
were assessed. The correlation was r = 0.79, r2 = 0.62.
Bias was -0.011 l/min/m2. Only a fraction of the cardiac
output measurements were performed in the ED, and
most came from the intensive care unit (ICU) [15].
In a study by Shoemaker et al. published in 1998, cor-
relations between the pulmonary artery thermodilution
method and the thoracic electrical bioimpedance device
by Renaissance Technologies were calculated separately
in the ED, the ICU, and the Operating Room (OR) [11].
However, this series did not consist of trauma patients
only. 52% (139 of 268) of the subjects had trauma-
related injuries, while the rest consisted of medical, non-
trauma emergencies. The correlation coefficient for the
entire population in the ED was r = 0.83, r2 = 0.68. Bias
and precision were -0.058 +/- 0.78 l/min/m2. In the OR,
these values improved to r = 0.88, r2 = 0.77, bias and pre-
cision = -0.027 +/-0.46 l/min/m2, but these differences
were not statistically significant. The authors considered
that the overall performance was satisfactory [11].
In 1999, Velmahos et al. evaluated 38 severely trauma-
tized patients on arrival in the ICU with the thoracic
electrical bioimpedance device from Renaissance Tech-
nologies, Newtown, Pennsylvania [2]. The investigators
calculated a correlation coefficient of r = 0.91, r2 = 0.83,
which they regarded as reasonably satisfactory. However,
as the pulmonary artery thermodilution method was initi-
ated after ICU arrival, these findings do not reflect the de-
vice’s performance in the ED [2]. A second study by the
same author included 134 patients with blunt trauma who
were assessed with the same devices on arrival in the ED.
A correlation coefficient of r = 0.83, r2 = 0.69 was found.
Bias and precision were -0.02 +/- 0.78 l/min/m2 [3].
The IQ System fromWantagh Inc., Bristol, Pennsylvania
is also based on the electrical bioimpedance technology
and was evaluated in two studies.[6,13] One was published
in 2001 by Shoemaker et al. [6]. These investigators calcu-
lated a correlation coefficient of r = 0.91, r2 = 0.83. Bias
and precision were -0.3 +/- 1.1 l/min/m2. The popula-
tion in this study consisted of 151 trauma patients and
the measurements were performed in the ED [6]. The
second study using the IQ System was executed by
Brown et al. in 2005 and included 285 critically injured
patients, with either blunt (85%) or penetrating traumas
(15%) [13]. In this study, the influence of the patient’s
age on the performance of non-invasive cardiac output
measurement was specifically evaluated. The investiga-
tors were concerned that atherosclerosis and a rigid
thoracic aorta could falsify the results. The study popu-
lation was stratified into three age groups: <55, 55-70,
and >70 years old. The correlation coefficients were
0.82, 0.87, and 0.80, respectively, while bias and precision
were -0.17 +/- 0.76 l/min/m2, -0.04 +/- 0.61 l/min/m2,and -0.04 +/-0.60 l/min/m2, respectively. Thus, good
correlations between the cardiac output values of the IQ
System and the pulmonary artery thermodilution
method were found, and no statistically significant
differences were detected between younger and older
patients [13].
Shoemaker et al. published a study in 2006 which eval-
uated the IQ model 101 from Noninvasive Medical
Technologies LLC, Las Vegas, Nevada, and the Physio-
Flow from VasoCOM, Bristol, Pennsylvania [5]. Both de-
vices are based on thoracic electrical bioimpedance. The
correlation coefficient was r = 0.915, r2 = 0.84. Bias and
precision was -0.07 +/- 0.47 l/min/m2. This was the only
study to calculate the limits of agreement (accuracy) be-
tween the bioimpedance and thermodilution methods,
which was 19.7% and considered to be acceptable
[5]. It has been suggested that limits of agreement
up to +/- 30% should be accepted when evaluating cardiac
output monitoring devices, because pulmonary artery
thermodilution itself has an inherent measurement error
of 10 to 20% [16,17].
Discussion
A total of five prospective observational and 2 retrospect-
ive studies investigating the accuracy of non-invasive
hemodynamic monitoring devices in trauma patients are
currently available. The thoracic electrical bioimpedance
methodology was used in all of these studies. The accur-
acy of non-invasive cardiac output monitoring was
broadly satisfactory.
Practicability and limitations of devices
Accuracy remains the most important aspect when
evaluating a new method or technology in patients’
hemodynamic monitoring. However, its limitations, us-
ability and convenience in daily clinical routine are
also important.
There are important limitations to non-invasive car-
diac output measurement that have been identified in
the past by several authors. Motion artifacts, restless-
ness, shivering, anxiety, hyperventilation and agitation
can interfere with the measurements [5,6,11]. However,
all these circumstances may also limit the accuracy
of pulmonary artery thermodilution and most other
hemodynamic monitoring techniques [8,11]. Faulty
electrode placement can obviously prevent good moni-
toring [5,6].
Moreover, extensive pulmonary edema, pleural effu-
sion, valvular heart disease, dysrhythmias, extensive
chest wall edema, and chest tubes parallel to the aorta
can reduce the impedance measured by the device, and
lead to false data [5,6,8,11]. In this case, the device’s
measurements do not provide a reliable basis for clinical
decisions [11].
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specific advantages of the non-invasive hemodynamic
monitoring devices. One is the continuous, on-line dis-
play of measurements [2,3,5,6,8,11,15,18]. This and the
real-time data presentation are very convenient [3,5,8,18].
It allows instant recognition of circulatory deterioration
and supports clinical decisions [2-4,11-13,15].
Another point that has been emphasized is that non-
invasive devices can be applied very early in the ED
[2-4,7,8,11,13,18]. The safety of the technology for
both patients and staff has been emphasized by many
authors [3,5,7,8,11,13,18]. The devices are very mobile
and convenient, which allows their use at the bedside
[7,8,11,18]. Their use is easy, quick and user-friendly
[1,3,6,11,15]. Finally, feasibility is good, as the learning
curve is short [3,5].Clinical impact
Most investigators have used the bioimpedance device
with other non-invasive techniques, such as pulse oxim-
etry, or measurements of transcutaneous oxygen and
carbon dioxide tension and non-invasive blood pressure
[2-8,11,12,18]. Thus, the clinician has indicators of car-
diac function (cardiac output, stroke volume), pulmon-
ary function (oxygen saturation) and tissue perfusion
(oxygen and carbon dioxide tension) [2,4].
The aforementioned early applicability of non-invasive
monitoring devices may solve a key problem of invasive
hemodynamic monitoring. It is known that invasive
hemodynamic techniques have important limitations,
especially in the treatment of trauma patients. For example,
inserting pulmonary artery catheters is time-consuming,
susceptible to complications, and personnel-intensive,
and may be difficult in severely injured patients [1-3].
Moreover, these catheters require a sterile critical care
environment and the cessation of other — possibly
more urgent — interventions [2-5,7]. In contrast, non-
invasive methods may be applied very early in the initial
evaluation of the trauma patient, even preclinically [2,11].
Moreover, they do not interfere with clinical management
[3]. The continuous real-time display of measurements
permits early recognition of circulatory abnormalities
or deterioration, which makes it possible to perform
early therapeutic interventions and to recognize their
hemodynamic effects [2,11]. Shoemaker et al. concluded
that non-invasive monitoring is of great value as a “front
end” device and may bridge the time to invasive monitor-
ing [11]. Moreover, the physiological parameters measured
by the device may permit early recognition of shock and
hypotension [3,5,6]. Earlier therapeutic intervention could
then be facilitated when time is crucial [2,6]. Further-
more, non-invasive monitoring can be used to titrate
therapy to appropriate therapeutic goals [5].Dunham et al. conducted a study on 270 consecutive
trauma activation patients in which they evaluated a
non-invasive cardiac output monitoring device [1].
These investigators concluded that the multiple associ-
ations of cardiac output with patient conditions imply
that non-invasive hemodynamic monitoring provides
an objective and clinically valid, relevant, and discrim-
inate measure of cardiac function in acutely injured
trauma activation patients. Moreover, they stated, that
the use of non-invasive hemodynamic monitoring may
be associated with a shorter length of stay in surviving
patients with complex injuries [1].
Shoemaker et al. considered that non-invasive moni-
toring could provide a means to develop an organized
coherent therapeutic plan based on physiological criteria
measured in the ED. This plan would accompany the pa-
tient as he/she proceeds to the OR, the radiology depart-
ment or the ICU [6].Future outlook
New devices with potentially better accuracy are emer-
ging. These devices should be evaluated for their impact
in routine work when taking care of traumatized patients.
Early differential diagnosis of hypotension in the initial
evaluation of trauma patient might be an important ad-
vantage of non-invasive hemodynamic monitoring.
Knowing the patient’s cardiac index early may help the
physician to differentiate between blood loss and other
causes of hypotension [1]. Thus, these devices may
help in determining the etiology of the illness.
If more were known about the hemodynamic changes
in bleeding trauma patients, this would help the clinician
in using the information gained by non-invasive devices.
Therefore, more data is required to interpret the mea-
surements performed early in the ED, e.g. for estimating
blood loss.Conclusion
The accuracy of non-invasive cardiac output monitoring
devices in trauma patients is broadly satisfactory. As the
devices can be applied very early in the shock room or
even preclinically, hemodynamic shock may be recog-
nized much earlier and therapeutic interventions could
be applied more rapidly and more adequately. The de-
vices can be used in the daily routine of a busy ED, as
they are non-invasive and easy to master. However, the
impact of non-invasive cardiac output monitoring on pa-
tients’ outcome is uncertain and more clinical experi-
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